|Articles|April 14, 2023
Pharma USA 2023: Digital Therapeutics and Pharma
Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.
Advertisement
Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Aidoc Submits Breakthrough-Designated Multi-Triage Device for FDA Approval
4
Next-Gen CDMOs: Keeping Pace With Industry Change
5
